Results 161 to 170 of about 182,433 (270)

P182 Low pre-treatment concentrations of HBV cccDNA transcriptional activity markers – HBcrAg and pre-genomic RNA can predict response to therapy with pegylated interferon, but not to bulevirtide monotherapy in chronic hepatitis D patients [PDF]

Ivana Carey, Zillah Cargill, Mark Anderson, James Lok, Gavin Cloherty, Geoffrey M Dusheiko, Kosh Agarwal   +6 more
openalex   +1 more source

Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation

British Journal of Pharmacology, Volume 183, Issue 20, Page 6225-6239, October 2026.
Abstract Background and Purpose Rare but severe adverse events (AEs) associated with mRNA‐lipid nanoparticle (LNP) COVID‐19 vaccines, such as Comirnaty, include anaphylaxis and inflammatory organ disorders, but their underlying mechanisms are poorly understood. We aimed to develop an animal model to study these phenomena.
László Dézsi, Gábor Kökény, Gábor Szénási, Csaba Révész, Tamás Mészáros, Bálint A. Barta, Réka Facsko, Anna Szilasi, Tamás Bakos, Gergely T. Kozma, Attila B. Dobos, Béla Merkely, Tamás Radovits, János Szebeni   +13 more
wiley   +1 more source

Sex Disparities in Hepatitis C Treatment Initiation: Role of Universal Access to DAA in France (ANRS FANTASIO 2)

Liver International, Volume 46, Issue 10, October 2026.
ABSTRACT Background and Aims Ensuring access to direct‐acting antivirals (DAA) for all individuals concerned is a priority in hepatitis C elimination efforts. We analysed sex disparities in DAA initiation in France over a 9‐year period spanning before and after August 2017, when the country implemented universal DAA access.
Fabienne Marcellin, Clémence Ramier, Cécile Brouard, Vincent Di Beo, Yoann Allier, Abbas Mourad, Morgane Bureau‐Stoltmann, Philippe Sogni, Sylvie Deuffic‐Burban, Patrizia Carrieri, Benjamin Rolland, Marc Bourliere, Camelia Protopopescu   +12 more
wiley   +1 more source

Interferons in the treatment of myeloproliferative neoplasms

Therapeutic Advances in Hematology
Interferons are cytokines with immunomodulatory properties and disease-modifying effects that have been used to treat myeloproliferative neoplasms (MPNs) for more than 35 years.
Pankit Vachhani, John Mascarenhas, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M. Palmer, Aaron T. Gerds, Lucia Masarova, Andrew T. Kuykendall, Raajit K. Rampal, Ruben Mesa, Srdan Verstovsek   +11 more
doaj   +1 more source

Severe MASLD and Metabolic Burden Are Associated with Reduced HBsAg Clearance During Pegylated Interferon Therapy in HBeAg-Negative Chronic Hepatitis B [PDF]

Pengxuan Wu, Jianxia Dong, Dacheng Sheng, Lilin Wang, Xinyue Meng, Jing Zhao, Shan Ren, Sujun Zheng   +7 more
openalex   +1 more source

The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism

HemaSphere, Volume 10, Issue 10, October 2026.
Charlotte Lees, Emile Brandt, Emmanuel Dutranoix, Gabriel Levy, Bogdan I. Iorga, Hosuk Ryou, Jens Rittscher, Daniel Royston, Stefan N. Constantinescu, Adam J. Mead   +9 more
wiley   +1 more source

Pegylated Interferon Alpha-2a Versus Standard Interferon Alpha-2a for Treatment-Naive Dialysis Patients with Chronic Hepatitis C: A Randomised Study

, 2011
Background: Chronic hepatitis C virus (HCV) infection is prevalent in dialysis patients, and standard interferon monotherapy is the current standard of care for such patients.
LIU, CHEN-HUA;LIANG, CHENG-CHAO;LIN, JOU-WEI;CHEN, SHIH-I;TSAI, HUNG-BIN;CHANG, CHI-SEN;HUNG, PEIR-HAUR;LIU, CHUN-JEN;LAI, MING-YANG;CHEN, JUN-HENG;CHEN, PEI-JER;KAO, JIA-HORNG;CHEN, DING-SHINN, 劉振驊;梁程超;林昭維;陳世宜;蔡宏斌;張繼森;洪培豪;劉俊人;賴明陽;陳俊恒;陳培哲;高嘉宏;陳定信   +1 more
core  

Cutaneous Reactions Induced by Pegylated-Interferon plus Ribavirin Combination Therapy in a Patient with Chronic Hepatitis C

, 2007
A 67 years old woman with chronic hepatitis C was treated with pegylated-interferon plus ribavirin combination therapy. Three weeks after starting the therapy, severe cutaneous adverse reaction occurred on her.
Dainichi, Teruki, Urabe, Kazunori, Enjoji, Munechika, 占部, 和敬, Gondo, Hisaki, 遠城寺, 宗近, 権藤, 寿喜, 大日, 輝記   +7 more
core  

Pegylated interferon‐α‐2a in severe Adamantiades‐Behçet disease: A series of seven cases [PDF]

Andreas Altenburg, Eleni Kourtellari, Lothar Krause, Christos C. Zouboulis   +3 more
openalex   +1 more source

NK cell reconfiguration and cytokine dynamics during pegylated interferon-α and nucleos(t)ide analogs combination therapy in chronic hepatitis B

李春梅, Xiang Liu, Gong Ming, Changhui Wu, Xiaojin Li, 周太成, Jia Wei, Hui Li   +7 more
openalex   +1 more source